Don't want ads? Subscribe or login now.

Eli Lilly Picks Up ImClone For $6.5B

By Julie Zeveloff · October 6, 2008, 12:00 AM EDT

Eli Lilly and Co. will purchase biotechnology company ImClone Systems Inc. in an all-cash deal valued at around $6.5 billion, giving Lilly access to ImClone's blockbuster cancer treatment Erbitux and a...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Julie

October 13, 2010
Cobalt Released From Sepracor Suit Over Sleep Drug
October 07, 2010
Pfizer Recalls 191,000 Lipitor Bottles Due To Odor
October 07, 2010
Endo, Watson Settle Litigation Over Opana ER Generic
October 05, 2010
Teva Sues Mylan, Others Over Proposed Azilect Generic
September 30, 2010
Novartis Contact Lens Patent Invalid, UK Court Affirms
September 23, 2010
US, EU Regulators Ban GSK's Avandia In Most Cases
August 11, 2010
Conceptus Falsely Marked Sterilization Kit, Rival Says
July 27, 2010
St. Jude Goes After Volcano Over Guide Wire Patents
July 26, 2010
Wyeth Bests Pa. Fen-Phen Hypertension Suit
July 16, 2010
King Pharma Sues Sandoz Over Generic EpiPen

Eli Lilly Picks Up ImClone For $6.5B

Related Sections

Recent Articles By Julie